Monogram Biosciences, Inc., (Nasdaq:MGRM) announced that it will hold a
conference call on Wednesday, May 6, 2009 at 4:30 p.m. (Eastern Time) to
discuss first quarter 2009 financial results. The call will be hosted by
Mr. William D. Young, Chairman and CEO of Monogram.
To participate in the live teleconference, please call (877) 545-1407,
or (719) 325-4847 for international callers, fifteen minutes before the
conference begins. Live audio of the call will be simultaneously
broadcast over the Internet and will be available to members of the news
media, investors and the general public. Following the live broadcast, a
replay of the call will also be available beginning at 9:30 p.m.
(Eastern Time) at (888) 203-1112, or (719) 457-0820 for international
callers, until 11:59 p.m. (Eastern Time) on Sunday, May 17, 2009. The
replay passcode is 8727141. Access to live and archived audio of the
conference call will be available by following the appropriate links at www.monogrambio.com
and clicking on the Investor Relations link.
The information provided on the teleconference is only accurate at the
time of the conference call, and Monogram will take no responsibility
for providing updated information except as required by law.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developing
and marketing innovative products to guide and improve treatment of
serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients
that lead to better outcomes and reduced costs. The Company's technology
is also being used by numerous biopharmaceutical companies to develop
new and improved antiviral therapeutics and vaccines as well as targeted
cancer therapeutics. More information about the Company and its
technology can be found on its web site at www.monogrambio.com.
Monogram Biosciences, Inc.
Alfred G. Merriweather, 650-624-4576
Chief
Financial Officer
amerriweather@monogrambio.com
or
Feinstein
Kean Healthcare
Jeremiah Hall, 415-677-2700
jeremiah.hall@fkhealth.com
